Brain autoantibodies in autism spectrum disorder

Biomarkers in Medicine

Volumn 8, Issue 3, 2014, Pages 345-352

  Elamin, Nadra E ^a   Al Ayadhi, Laila Y ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

animal models; autism; autoimmunity; brain autoantibodies; BTBR mice; maternal antibodies; neurodevelopmental disorders

Indexed keywords

AUTOANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; GANGLIOSIDE GM1; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; NEUROTROPHIN; PHOSPHOLIPID ANTIBODY; BIOLOGICAL MARKER; NERVE PROTEIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; AUTISM; AUTOIMMUNITY; BRAIN LEVEL; BRAIN TISSUE; DEMYELINATION; DISEASE MODEL; HUMAN; INTELLECTUAL IMPAIRMENT; MATERNAL BLOOD; MOTHER CHILD RELATION; NERVE DEGENERATION; NEUROPATHOLOGY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOSOCIAL DEVELOPMENT; REVIEW; ANIMAL; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; HUMANS; NERVE TISSUE PROTEINS;

EID: 84898423620     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.14.1     Document Type: Review

References (68)

1. CDC. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill. Summ. 61(3), 1-19 (2012).
2. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann. NY Acad. Sci. 1107(1), 79-91 (2007).
3. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, DC, USA (2000).
4. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 66(10), 3-8 (2005).
5. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J. Leuk. Biol. 80(1), 1-15 (2006).
6. Croen LA, Braunschweig D, Haapanen L et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: the Early Markers for Autism study. Biol. Psychiatry 64(7), 583-588 (2008).
7. Ratajczak HV. Theoretical aspects of autism: causes - a review. J. Immunotoxicol. 8(1), 68-79 (2011).
8. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 26(4), 607-616 (2012).
9. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112(5), e420-e424 (2003).
10. Cohly HH, Panja A. Immunological findings in autism. Int. Rev. Neurobiol. 71, 317-341 (2005).
11. Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J. Neuroimmunol. 178(1), 149-155 (2006).
12. Singh VK. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann. Clin. Psychiatry 21(3), 148-161 (2009).
13. Singh VK, Jensen RL. Elevated levels of measles antibodies in children with autism. Pediatr. Neurol. 28(4), 292-294 (2003).
14. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int. Rev. Psychiat. 17(6), 485-495 (2005).
15. Odell D, Maciulis A, Cutler A et al. Confirmation of the association of the C4B null allelle in autism. Hum. Immunol. 66(2), 140-145 (2005).
16. Watts TJ. The pathogenesis of autism. Clin. Med. Pathol. 1, 99-103 (2008).
17. Mostafa GA, Shehab AA, AL-Ayadhi LY. The link between some alleles on human leukocyte antigen system and autism in children. J. Neuroimmunol. 255(1-2), 70-74 (2013).
18. Braunschweig D, Ashwood P, Krakowiak P et al. Autism: maternally derived antibodies specific for fetal brain proteins. NeuroToxicology 29 (2), 226-231 (2008).
19. Nordahl CW, Braunschweig D, Iosif AM et al. Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav. Immun. 30, 61-65 (2013).
20. Bauman MD, Iosif AM, Ashwood P et al. Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl. Psychiatry 3, e278 (2013).
21. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14(6), 388-394 (1999).
22. Mostafa GA, AL-Ayadhi LY. The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children. J. Neuroimmunol. 261(1-2), 77-81 (2013).
23. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? Maybe it's the antibodies. Nat. Rev. Immunol. 9(6), 445-456 (2009).
24. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7(1), 97-103 (1993).
25. Singh VK, Rivas WH. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 355(1-2), 53-56 (2004).
26. Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr. Neurol. 40(2), 107-112 (2009).
27. Mostafa GA, AL-Ayadhi LY. Increased serum levels of antiganglioside M1 autoantibodies in autistic children: relation to the disease severity. J. Neuroinflammation 8, 39 (2011).
28. Mostafa GA, AL-Ayadhi LY. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur. J. Paediatr. Neurol. 16(5), 464-468 (2012).
29. Rossi CC, Joaquin Fuentes J, Van de Water J, Amaral DG. Brief report: antibodies reacting to brain tissue in Basque Spanish children with autism spectrum disorder and their mothers. J. Autism Dev. Disord. doi:10.1007/s10803- 013-1859-y (2013) (Epub ahead of print).
30. Vural B, Ugurel E, Tuzun E et al. Anti-neuronal and stress induced-phosphoprotein 1 antibodies in neuro-Behcet's disease. J. Neuroimmunol. 239, 91-97 (2011).
31. Hensley K, Venkova K, Christov A, Gunning W, Park J. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43, 180-191 (2011).
32. Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol. Psychiatry 18, 369-381 (2013).
33. Aboul-Enein F, Rauschka H, Kornek B et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62(1), 25-33 (2003).
34. Mostafa GA, AL-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum antimyelin basic protein auto-antibodies in autistic children. J. Neuroinflammation 8, 71 (2011).
35. Angelucci F, Mirabella M, Frisullo G, Caggiula M, Tonali PA, Batocchi AP. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy. Dis. Markers 21, 49-55 (2005).
36. Hedegaard CJ, Chen N, Sellebjerg F et al. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP. Immunology 128, e451-e461 (2009).
37. Nelson KB, Grether JK, Croen LA et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49, 597-606 (2001).
38. Connolly AM, Chez M, Streif EM et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau- Kleffner syndrome, and epilepsy. Biol. Psychiatry 59 (4), 354-363 (2006).
39. Hashimoto K, Iwata Y, Nakamura K et al. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1529-1531 (2006).
40. Moeller S, Lau NM, Green PH et al. Lack of association between autism and anti-GM1 ganglioside antibody. Neurology 81(18), 1640-1641 (2013).
41. Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P. Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm. 2013, 935608 (2013).
42. Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17(1), 88-90 (1997).
43. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134(5), 607-613 (1999).
44. Goines P, Haapanen L, Boyce R et al. Autoantibodies to cerebellum in children with autism associate with behavior. Brain. Behav. Immun. 25(3), 514-523 (2011).
45. Silva SC, Correia C, Fesel C et al. Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 152(1-2), 176-182 (2004).
46. Vojdani A, O'Bryan T, Green JA et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr. Neurosci. 7(3), 151-161 (2004).
47. Chez MG, Connolly AM, Nowinski C, Buchanan C. The presence of autoantibodies in idiopathic/acquired versus genetic variants of pediatric epilepsy. Epilepsia 41S, 183 (2000).
48. Aschner M, Allen JW, Kimelberg HK, LoPachin RM, Streit WJ. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39, 151-173 (1999).
49. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57(1), 67-81 (2005).
50. Mazur-Kolecka B, Cohen IL, Gonzalez M et al. Autoantibodies against neuronal progenitors in sera from children with autism. Brain Dev. doi:10.1016/j.braindev.04.015 (2013) (Epub ahead of print).
51. Rossi CC, Van de Water J, Rogers SJ, Amaral DG. Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav. Immun. 25, 1123-1135 (2011).
52. Dalton P, Deacon R, Blamire A et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 53(4), 533-537 (2003).
53. Singer HS, Moriss CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 194(1-2), 165-172 (2008).
54. Schwartzer JJ, Careaga M, Onore CE, Rushakoff JA, Berman RF, Ashwood P. Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl. Psychiatry 12, e240 (2013).
55. Gesundheit B, Rosenzweig JP, Naor D et al. Immunological and autoimmune considerations of autism spectrum disorders. J. Autoimmun. 44, 1-7 (2013).
56. Zimmerman AW, Connors SL, Matteson KJ et al. Maternal antibrain antibodies in autism. Brain Behav. Immun. 21, 351-357 (2007).
57. Fox E, Amaral D, Van de Water J. Maternal and fetal anti-brain antibodies in development and disease. Develop. Neurobiol. 72(10), 1327-1334 (2012).
58. Braunschweig D, Golub MS, Koenig CM et al. Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model. J. Neuroimmunol. 252(1-2), 56-65 (2012).
59. Brimberg L, Sadiq A, Gregersen PK, Diamond B. Brainreactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol. Psychiatry 18, 1171-1177 (2013).
60. Atladottir HO, Pedersen MG, Thorsen P et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124, 687-694 (2009).
61. Patterson PH. Modeling autistic features in animals. Pediatr. Res. 69(3), 34R-40R (2011).
62. Heo Y, Zhang Y, Gao D, Miller VM, Lawrence DA. Aberrant immune responses in a mouse with behavioral disorders. PLoS ONE 6(7), e20912 (2011).
63. Onore CE, Careaga M, Babineau BA, Schwartzer JJ, Berman RF, Ashwood A. Inflammatory macrophage phenotype in BTBR T+tf/J mice. Front. Neurosci. 7, 158 (2013).
64. Braunschweig D, Krakowiak P, Duncanson P et al. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl. Psychiatry 3, e277 (2013).
65. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 22(6), 806-816 (2008).
66. Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J. Neuroimmunol. 211(1-2), 39-48 (2009).
67. Volkmar FR, Lord C, Bailey A, Schultz RT, Klin A. Autism and pervasive developmental disorders. J. Child Psychol. Psychiatry 45(1), 135-170 (2004).
68. Russo AJ, Krigsman A, Jepson B, Wakefield A. Generalized autoimmunity of ANCA and ASCA related to severity of disease in autistic children with GI disease. Immunol. Immunogenet. Insights 1, 37-47 (2009).